Detection Test By Nucleic Acid For Digestive Tract Pathogen, Multiple Types Or Subtypes, 3-5 Targets in New Jersey
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in New Jersey
| Provider | Medicare | Services |
|---|---|---|
| Genesis Laboratory Management, Llc | $125.72 | 98 |
| Aculabs Inc | $123.88 | 80 |
| Laboratory Corporation Of America... | $111.04 | 11 |
New Jersey Pricing in Context
In New Jersey, CPT code 87505 (Detection Test By Nucleic Acid For Digestive Tract Pathogen, Multiple Types Or Subtypes, 3-5 Targets) carries an average Medicare payment of $124.13 — 1% below the national benchmark of $124.77. 7 providers across the state submitted claims for this procedure in 2023, performing 194 total services. Individual payments in NJ ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in New Jersey is $152.75, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because New Jersey sits below the national Medicare average, commercial rates in the state may also run lower than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Laboratory procedures, the estimated commercial insurance price in New Jersey lands near $316.53, with self-pay cash prices typically around $135.10. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Detection Test By Nucleic Acid For Digestive Tract Pathogen, Multiple Types Or Subtypes, 3-5 Targets cost in New Jersey?
The average Medicare payment for Detection Test By Nucleic Acid For Digestive Tract Pathogen, Multiple Types Or Subtypes, 3-5 Targets in New Jersey is $124.13, which is 1% below the national average of $124.77. Providers in NJ typically bill $152.75 for this procedure.
What does Detection Test By Nucleic Acid For Digestive Tract Pathogen, Multiple Types Or Subtypes, 3-5 Targets cost with insurance in New Jersey?
With commercial insurance in New Jersey, Detection Test By Nucleic Acid For Digestive Tract Pathogen, Multiple Types Or Subtypes, 3-5 Targets costs an estimated $316.53. Without insurance, the estimated cash price is $135.10. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Detection Test By Nucleic Acid For Digestive Tract Pathogen, Multiple Types Or Subtypes, 3-5 Targets in New Jersey?
7 providers in New Jersey billed Medicare for Detection Test By Nucleic Acid For Digestive Tract Pathogen, Multiple Types Or Subtypes, 3-5 Targets in 2023, performing 194 total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Detection Test By Nucleic Acid For Digestive Tract Pathogen, Multiple Types Or Subtypes, 3-5 Targets cheaper in New Jersey than the national average?
Yes — Detection Test By Nucleic Acid For Digestive Tract Pathogen, Multiple Types Or Subtypes, 3-5 Targets costs 1% below the national average in New Jersey. The state average Medicare payment is $124.13 compared to $124.77 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.